Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pfizer
Related studies linked through entity extraction aliases.
Participatory Action Research to Evaluate the Delivery of the MISSION ABC Service Model and Assess Health Service and Clinical Outcomes
- Status
- COMPLETED
- Phase
- N/A
Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571
- Status
- COMPLETED
- Phase
- PHASE1
Clostridium Difficile Vaccine Efficacy Trial
- Status
- COMPLETED
- Phase
- PHASE3
Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Personalising Anti-TNF Therapy in Crohns Disease (PANTS)
- Status
- UNKNOWN
- Phase
- N/A
Treatment With Crizotinib Single Patient Expanded Access IND 134375
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Effect of Itraconazole and Rifampin on the Pharmacokinetics of Talazoparib in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Statin Mechanism Preventing Cardiovascular Disease by Post-hoc Analysis of Treating to New Targets Study
- Status
- COMPLETED
- Phase
- PHASE4
Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions
- Status
- COMPLETED
- Phase
- N/A
A Study of Talazoparib in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment.
- Status
- COMPLETED
- Phase
- PHASE2
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A
- Status
- COMPLETED
- Phase
- PHASE2
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2